Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 4/20 | 0.65 |
| ▸ | F2 | P00734 | 1/20 | 0.65 |
| ▸ | KLKB1 | P03952 | 16/20 | 0.52 |
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | F9 | P00740 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3831502 | 0.86 | F10 (0.65) | F10F2KLKB1F9 | |
| SCHEMBL3830123 | 0.85 | F10 (0.69) | F10F2KLKB1PRSS1PRSS2 | |
| SCHEMBL7540360 | 0.84 | KMT2A (0.56) | F10KLKB1PLGPRSS1PRSS2 | |
| SCHEMBL3832841 | 0.83 | KLKB1 (0.55) | F10F2KLKB1PLGPRSS1 | |
| SCHEMBL31067480 | 0.82 | KLKB1 (0.58) | F10F2KLKB1PLGPRSS1 | |
| SCHEMBL31067479 | 0.82 | KLKB1 (0.54) | F10F2KLKB1PLGPRSS1 | |
| SCHEMBL18605173 | 0.82 | KLKB1 (0.58) | F10F2KLKB1PLGPRSS1 | |
| SCHEMBL17064543 | 0.82 | KLKB1 (0.54) | F10F2KLKB1PLGPRSS1 | |
| Trifluoroacetic Acid SCHEMBL3829623 | 0.82 | F10 (0.65) | F10F2KLKB1PRSS1PRSS2 | |
| SCHEMBL7412791 | 0.81 | KLKB1 (0.48) | F10F2KLKB1PLGPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0946508-B1 | NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2009-09-23 | — | — | EP | disclosed |
| US-6548512-B1 | Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-04-15 | — | — | US | disclosed |
| CN-1246847-A | Nitrogen containing heteroaromatics as factor Xa inhibitors | DU PONT MERCK PHARMA (US) | 2000-03-08 | — | — | CN | disclosed |
| US-6020357-A | CARDIOVASCULAR DISORDERS; ANTCOAGULANTS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-02-01 | — | — | US | disclosed |